Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

Amgen, Cytokinetics’ heart failure drug disappoints in phase 3

Drug hit primary endpoint but missed secondary endpoint of reduction in cardiovascular death

- PMLiVE

FDA publishes new guidelines for COVID-19 vaccine approval

New rules mean a COVID-19 shot is unlikely to be approved pre-election in the US

- PMLiVE

EU announces agreement with Gilead for remdesivir supply

Drug was granted conditional marketing authorisation in the EU in July

- PMLiVE

Lucid Group sets the vision for its team of committed Mental Health First Aiders

As we approach World Mental Health Day, Lucid's team of Mental Health First Aiders reflect on their training and set the vision for how they will be supporting the organisation...

Lucid Group Communications Limited

Medical Modeling in Virtual Reality

Justin Sutherland, Co-founder and President of Realize Medical, delves into a range of topics around virtual reality (VR) and three-dimensional modeling, including the roles of VR in medical education, training, surgery planning,...

Impetus Digital

Using Healthtech to Deliver Better Patient Outcomes

Peter Birch, General Manager (Asia Pacific) at MetaOptima Technologies & host of the “Talking HealthTech Podcast.” joins us to discuss a whole range of topics, including Peter’s professional journey and the...

Impetus Digital

Accelerating Digital Health Innovation Success

Fard Johnmar, Founder of Enspektos, and Denise Pines, President of the Medical Board of California, discuss the concepts of “FemAging” and “ePatients”, and how COVID-19 has affected both of these. We explore an...

Impetus Digital

- PMLiVE

J&J signs deal with EU for 200 million COVID-19 vaccine doses

EU member states will have an option to secure 200 million additional doses

- PMLiVE

The Patient as Priority: How can effective internal training contribute to improving patient outcomes?

Hear from OPEN Health's Briony Frost

OPEN Health

- PMLiVE

BMS’ Opdivo is first immunotherapy to score phase 3 win in pre-surgery NSCLC

Checkpoint inhibitor plus chemo meets first primary endpoint in late-stage trial

- PMLiVE

Lilly seeks US emergency approval after posting new data for COVID-19 antibodies

Combination of two antibodies reduced viral load and symptoms of COVID-19

China flag thumb

Experimental Chinese COVID-19 vaccine is safe, according to researchers

Safety data was published on pre-print server medRxiv

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links